Your browser doesn't support javascript.
loading
Hemostatic Management in an Infant With Neuroblastoma and Severe Hemophilia B With Extended Half-life Recombinant Factor IX Fusion Protein.
Cuntz, Franziska; Deubzer, Hedwig E; Schulte, Johannes H; Nimtz-Talaska, Antje; Eggert, Angelika; Holzhauer, Susanne.
Affiliation
  • Cuntz F; Department of Pediatric Hematology and Oncology, Charité University Medicine.
  • Deubzer HE; Department of Pediatric Hematology and Oncology, Charité University Medicine.
  • Schulte JH; Experimental and Clinical Research Center (ECRC), Charité and Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin.
  • Nimtz-Talaska A; Department of Pediatric Hematology and Oncology, Charité University Medicine.
  • Eggert A; Pediatric Outpatient Practice, Frankfurt (Oder), Germany.
  • Holzhauer S; Department of Pediatric Hematology and Oncology, Charité University Medicine.
J Pediatr Hematol Oncol ; 44(1): e246-e249, 2022 01 01.
Article in En | MEDLINE | ID: mdl-33661164
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Factor IX / Hemostatics / Hemophilia B / Stem Cell Transplantation / Neuroblastoma Limits: Humans / Infant / Male Language: En Journal: J Pediatr Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2022 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Factor IX / Hemostatics / Hemophilia B / Stem Cell Transplantation / Neuroblastoma Limits: Humans / Infant / Male Language: En Journal: J Pediatr Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2022 Document type: Article Country of publication: Estados Unidos